Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients With Severe Eosinophilic Asthma

Journal of Investigational Allergology and Clinical Immunology ◽

10.18176/jiaci.0285 ◽

2019 ◽

Vol 29 (1) ◽

pp. 40-45 ◽

Author(s):

M Kurosawa ◽

E Sutoh

Keyword(s):

Subcutaneous Administration ◽

Japanese Patients ◽

Eosinophilic Asthma ◽

Open Label Study ◽

Label Study ◽

Severe Eosinophilic Asthma

Download Full-text

Prospective Open-Label Study of 48-Week Subcutaneous Administration of Mepolizumab in Japanese Patients with Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2018.12.313 ◽

2019 ◽

Vol 143 (2) ◽

pp. AB103

Author(s):

Motohiro Kurosawa

Keyword(s):

Subcutaneous Administration ◽

Japanese Patients ◽

Eosinophilic Asthma ◽

Open Label Study ◽

Label Study ◽

Severe Eosinophilic Asthma

Download Full-text

Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study

The Journal of Dermatology ◽

10.1111/1346-8138.14294 ◽

2018 ◽

Vol 45 (5) ◽

pp. 529-539 ◽

Author(s):

Shigetoshi Sano ◽

Hiroshi Kubo ◽

Hitomi Morishima ◽

Ryosuke Goto ◽

Richuan Zheng ◽

...

Keyword(s):

Monoclonal Antibody ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Generalized Pustular Psoriasis ◽

Erythrodermic Psoriasis ◽

Download Full-text

Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study

Modern Rheumatology ◽

10.1080/14397595.2019.1583832 ◽

2019 ◽

Vol 30 (1) ◽

pp. 93-100 ◽

Author(s):

Tsutomu Takeuchi ◽

Yoshiya Tanaka ◽

Ryutaro Matsumura ◽

Kazuyoshi Saito ◽

Mitsuhiro Yoshimura ◽

...

Keyword(s):

Systemic Lupus Erythematosus ◽

Lupus Erythematosus ◽

Japanese Patients ◽

Interferon Α ◽

Phase 2 ◽

Systemic Lupus ◽

Open Label Study ◽

Label Study ◽

Multicenter Phase

Download Full-text

Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-016-1052-3 ◽

2016 ◽

Vol 22 (1) ◽

pp. 79-79 ◽

Author(s):

Noboru Yamamoto ◽

Koichi Goto ◽

Makoto Nishio ◽

Kenichi Chikamori ◽

Toyoaki Hida ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Egfr Mutation ◽

Japanese Patients ◽

Small Cell Lung ◽

Open Label Study ◽

Download Full-text

Abstract C37: A Phase 1 open‐label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors

10.1158/1535-7163.targ-09-c37 ◽

2009 ◽

Author(s):

Tomohide Tamura ◽

Noboru Yamamoto ◽

Hiroshi Nokihara ◽

Yasuhide Yamada ◽

Hajime Asahina ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Japanese Patients ◽

Open Label Study ◽

Download Full-text

Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial

Epilepsy Research ◽

10.1016/j.eplepsyres.2016.01.002 ◽

2016 ◽

Vol 121 ◽

pp. 1-7 ◽

Author(s):

Yoko Ohtsuka ◽

Harumi Yoshinaga ◽

Yukiyoshi Shirasaka ◽

Rumiko Takayama ◽

Hiroki Takano ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Japanese Patients ◽

Seizure Outcome ◽

Open Label Study ◽

Download Full-text

Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis

International Journal of Hematology ◽

10.1007/s12185-016-2130-z ◽

2016 ◽

Vol 105 (3) ◽

pp. 309-317 ◽

Author(s):

Norio Komatsu ◽

Keita Kirito ◽

Kazuya Shimoda ◽

Takayuki Ishikawa ◽

Kohshi Ohishi ◽

...

Keyword(s):

Japanese Patients ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study

The Journal of Dermatology ◽

10.1111/1346-8138.13497 ◽

2016 ◽

Vol 44 (1) ◽

pp. 13-17 ◽

Author(s):

Yasuhito Hamaguchi ◽

Takayuki Sumida ◽

Yasushi Kawaguchi ◽

Hironobu Ihn ◽

Sumiaki Tanaka ◽

...

Keyword(s):

Systemic Sclerosis ◽

Japanese Patients ◽

Digital Ulcers ◽

Open Label Study ◽

Download Full-text

Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study

Journal of the Neurological Sciences ◽

10.1016/j.jns.2016.01.046 ◽

2016 ◽

Vol 362 ◽

pp. 266-271 ◽

Author(s):

Yukio Ando ◽

Yoshiki Sekijima ◽

Konen Obayashi ◽

Taro Yamashita ◽

Mitsuharu Ueda ◽

...

Keyword(s):

Japanese Patients ◽

Familial Amyloid Polyneuropathy ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label Study ◽

Label Study ◽

Amyloid Polyneuropathy

Download Full-text

Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty‐six‐week phase 3 open‐label study

The Journal of Dermatology ◽

10.1111/1346-8138.15533 ◽

2020 ◽

Vol 47 (12) ◽

pp. 1383-1390

Author(s):

Kenshi Yamasaki ◽

Keiichi Yamanaka ◽

Yiwei Zhao ◽

Shunsuke Iwano ◽

Keiko Takei ◽

...

Keyword(s):

Pyoderma Gangrenosum ◽

Japanese Patients ◽

Phase 3 ◽

Open Label Study ◽

Download Full-text